Skip to main content

Table 3 Genotype distribution across mammographic density Vermont cohort

From: A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer

Mammographic density <50%

rs8176318 positive

rs8176318 negative

p-value*

Full cohort

93

70

0.2948

Pre-menopausal

49

39

0.7842

Post-menopausal

35

28

0.2530

Normal BMI

26

22

0.7342

Overweight BMI

29

20

0.3115

Obese BMI

36

26

0.0398

Menarche age 7-11

16

17

0.7848

Menarche age 12-13

48

33

0.4672

Menarche age ≥14

18

9

0.2123

  1. *P-values represent significance of the association between mammographic density and the presence or absence of rs8176318.